soluble VCAM-1
Selected indexed studies
- ICAM-1 and VCAM-1: Gatekeepers in various inflammatory and cardiovascular disorders. (Clin Chim Acta, 2023) [PMID:37442359]
- [Soluble VCAM-1]. (Nihon Rinsho, 2002) [PMID:12355797]
- [Soluble VCAM-1]. (Nihon Rinsho, 1998) [PMID:9513416]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. (1992) pubmed
- ICAM-1 and VCAM-1: Gatekeepers in various inflammatory and cardiovascular disorders. (2023) pubmed
- [Soluble VCAM-1]. (2002) pubmed
- [Soluble VCAM-1]. (1998) pubmed
- Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer. (2020) pubmed
- Preoperative soluble VCAM-1 contributes to predict late mortality after coronary artery surgery. (2020) pubmed
- Soluble VCAM-1/soluble ICAM-1 ratio is a promising biomarker for diagnosing endometriosis. (2017) pubmed
- Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling. (2015) pubmed
- VCAM-1 as a predictor biomarker in cardiovascular disease. (2021) pubmed
- Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. (2002) pubmed